In patients with #SHTG and metabolic dysfunction-associated steatotic liver disease (#MASLD), just 4 weeks of treatment produced: Up to 57% reductions in triglycerides Over 50% reductions in remnant cholesterol a key driver of residual cardiovascular risk with no changes in LDL-C or HDL-C ~30% improvements in liver fat A favorable safety and tolerability profile Notably, in patients with the most severely elevated triglycerides (500 mg/dL) those at highest risk for acute pancreatitis both doses produced consistent ~62% reductions, reinforcing the strength of this signal in the patients who need it most
Di Pietro G, Magno LA, Rios-Santos F
15,272 GLP-1RAs and joint disorders GLP-1RAs in OA GLP-1R expression was detected via immunohistochemistry in articular chondrocytes from both normal and osteoarthritic individuals
Vanessa Mack (Dean) you review your insurance policy, and if you are unable to find a definitive answer there, you can also reach out to your insurance provider to determine if Seamglutide would be covered, or if you would have to co-pay, or potentially only have a small portion covered by insurance
Pigmentation Changes: Of course, the primary and intended effect is the darkening of skin
In: PortincasaPFrhbeckGNathoeHM, editors
